|
Phase II Randomized Study of Gemcitabine and Cisplatin With or Without Bevacizumab in Patients With Malignant Mesothelioma
Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as bevacizumab can locate tumor cells and kill them without harming normal cells. It is not yet known if combination chemotherapy is more effective with or without bevacizumab in treating malignant mesothelioma. This is a Randomized phase II trial to compare the effectiveness of combination chemotherapy with or without bevacizumab in treating patients who have malignant mesothelioma.
Location/Contacts:
University of Chicago Cancer Research Center
Hedy L. Kindler, MD, Protocol Chair
Ph: 773-702-0360; 1-888-824-0200 California Duarte
City of Hope Comprehensive Cancer Center
Marianna Koczywas, MD
Ph: 626-359-8111
1-800-826-4673
mkocywas@coh.org Pasadena
City of Hope Medical Group
Mark V. McNamara, MD
Ph: 626-396-2900
mmcnmara@ccsmg.com Sacramento
University of California Davis Cancer Center
David R. Gandara, MD
Ph: 916-734-3772
dgandara@cc.ucdmc.ucdavis.edu Illinois Chicago
Louis A. Weiss Memorial Hospital
Gary D. Steinberg, MD
Ph: 773-564-5272 University of Chicago Cancer Research Center
Hedy L. Kindler, MD
Ph: 773-702-0360
1-888-824-0200 Decatur
Decatur Memorial Hospital Cancer Center Institute
James L. Wade, MD
Ph: 217-876-6603 Harvey
Ingalls Memorial Hospital
Mark F. Kozloff, MD
Ph: 708-333-2300. Sulochana D. Yalavarthi, MD
Ph: 708-915-6620 LaGrange
LaGrange Memorial Hospital
James E. Hannigan, MD
Ph: 708-579-3418 Renee H. Jacobs, MD
Ph: 708-579-3418 Maywood
Loyola University Medical Center
Joseph I. Clark, MD
Ph: 708-327-3236
jclark@lumc.edu Kathy S. Albain, MD
Ph: 708-327-3102
kalbain@lumc.edu Peoria
Oncology/Hematology Associates of Central Illinois, P.C.
James A. Knost, MD, FACP
Ph: 309-672-5681 John W. Kugler, MD
Ph: 309-671-3605 Indiana
Fort Wayne
Fort Wayne Medical Oncology and Hematology, Inc.
David Frank Sciortino, MD
Ph: 219-484-8830 Sreenivasa Rao Nattam, MD
Ph: 219-484-8830
800-852-2333
ledgar@fwmoh.com South Bend
CCOP-Northern Indiana CR Consortium
David Allen Taber, MD
Ph: 800-284-7370 Rafat H. Ansari, MD, FACP
Ph: 219-234-5123 Michigan
Saint Joseph
Lakeland Medical Center - St. Joseph
Eric Lester, MD
Ph: 616-982-4963 New York
New York
Memorial Sloan-Kettering Cancer Center
Lee M. Krug, MD
Ph: 212-639-8420 Pennsylvania
Philadelphia
University of Pennsylvania Cancer Center
James Stevenson, MD
Ph: 215-662-8756 Texan
Houston
University of Texas - MD Anderson Cancer Center
Charles Lu, MD
Ph: 713-792-6363
1-800-392-1611
|
